Anti-HIV drug available in trials
Randall, P.S.
Postgraduate Medicine 88(7): 23
1990
ISSN/ISBN: 0032-5481 PMID: 2122427 Document Number: 360035
Document emailed within 1 workday
Related Documents
Zlydnikov, D.M. 1981: Experience with clinical trials of the new anti-influenza drug rimantadine Vrachebnoe Delo 4: 15-18Bellamy, N.; Carette, S.; Ford, P.M.; Kean, W.F.; le Riche, N.G.; Lussier, A.; Wells, G.A.; Campbell, J. 1992: Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise Journal of Rheumatology 19(3): 451-457
Davis, T.; Gore-Langton, R.E.; Cheson, B.D. 2000: Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab Oncology 14(10): 1437; 1440-1443
Bellamy, N.; Anastassiades, T.P.; Buchanan, W.W.; Davis, P.; Lee, P.; McCain, G.A.; Wells, G.A.; Campbell, J. 1991: Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugs Journal of Rheumatology 18(12): 1901-1907
Ayala, R.C.; Arya, V.; Younis, I.R. 2016: Design Features of Drug-Drug Interaction Trials Between Antivirals and Oral Contraceptives Journal of Clinical Pharmacology 56(5): 541-547
Nakamura, H.; Kadokawa, T.; Nakatsuji, K.; Nakamura, K. 1970: Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. I. Anti-inflammatory, analgesic and anti-pyretic activity Arzneimittel-Forschung 20(8): 1032-1046
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168
Beggs, W.H. 1993: Anti-Candida activity of the anti-cancer drug tamoxifen Research Communications in Chemical Pathology and Pharmacology 80(1): 125-128
Talwar, G.P.; Singh, O.; Pal, R.; Chatterjee, N. 1992: Anti-hCG vaccines are in clinical trials Scandinavian Journal of Immunology. Suppl 11: 123-126
Gralla, R.J.; Clark, R.A.; Kris, M.G.; Tyson, L.B. 1991: Methodology in anti-emetic trials European Journal of Cancer 27(Suppl 1): S5
Kumar, S.; Rao, P.S.S.; Earla, R.; Kumar, A. 2015: Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems Expert Opinion on Drug Metabolism and Toxicology 11(3): 343-355
Bunton, R.W. 1983: Reintroduction of anti-inflammatory drug therapy after drug-associated gastrointestinal disturbances New Zealand Medical Journal 96(726): 144
Gleiter, C.H.; Bieck, P.R. 1991: Clinical drug trials. 1: the 4 phases of clinical trials Fortschritte der Medizin 109(5): 136-137
Hegazy, S.K.; El-Azab, G.A.; Zakaria, F.; Mostafa, M.F.; El-Ghoneimy, R.A. 2022: Mebendazole; from an anti-parasitic drug to a promising candidate for drug repurposing in colorectal cancer Life Sciences 299: 120536
Dworacka, M.; Nowocień, T. 2017: Undesirable pharmacokinetic drug-to-drug interactions affecting the effectiveness and safety of anti-infectious pharmacotherapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 42(248): 61-64
Mangesho, P.E.; Reynolds, J.; Lemnge, M.; Vestergaard, L.S.; Chandler, C.I.R. 2014: "Every drug goes to treat its own disease…" - a qualitative study of perceptions and experiences of taking anti-retrovirals concomitantly with anti-malarials among those affected by HIV and malaria in Tanzania Malaria Journal 13: 491
Aukrust, P.ål.; Yndestad, A.; Ueland, T.; Damås, J.K.; Gullestad, L. 2006: Anti-inflammatory trials in chronic heart failure Heart Failure Monitor 5(1): 2-9
Jaillon, P. 1985: Drug trials in man Revue de l'Infirmiere 35(11): 23-27
Yamada, Y.; Nakahara, M.; Kohno, M.; Otsuka, M.; Takaiti, O. 1989: Metabolic fate of the new anti-ulcer drug enprostil in animals. 4th communication: effect on hepatic drug metabolizing enzyme system in rats Arzneimittel-Forschung 39(3): 356-360
da Silva, L.C.; Sette, H.; Chamone, D.A.; Sáez-Alquezar, A.; Punskas, J.A.; Raia, S. 1975: Further clinical trials with oxamniquine (UK 4271), a new anti-schistosomal agent Revista do Instituto de Medicina Tropical de Sao Paulo 17(5): 307-311